http://www.lse.co.uk/ GWP Financial Share News Feed - London South East en-us Sun, 19 May 2013 00:23:59 GMT 2007 London South East http://www.lse.co.uk/rss/ 15 LONDON, Dec 13 (Reuters) - There is little evidence to back the use of a cannabis extract spray made by GW Pharmaceuticals for spasticity in patients with multiple sclerosis, according to a medical journal review published on Thursday. http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=slmlaqce2u4yyi9 Wed, 12 Dec 2012 23:45:01 GMT LONDON, Oct 12 (Reuters) - GW Pharmaceuticals PLC: * Positive German sativex data presented at ectrims http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=zc0shkcofjcvkuo Fri, 12 Oct 2012 06:31:11 GMT LONDON, Oct 1 (Reuters) - GW Pharmaceuticals PLC: * Appointment of chief operating officer http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=09m2dzxwcm6i7dz Mon, 01 Oct 2012 06:32:48 GMT LONDON, Sept 13 (Reuters) - A British drug company aims to test a compound found in cannabis as a treatment for epilepsy, following a promising study using the chemical in rats and mice. http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=nefsw8tdu1hrbpy Thu, 13 Sep 2012 07:38:14 GMT LONDON, June 22 (Reuters) - GW Pharmaceuticals PLC: * German G-BA establishes positive additional benefit of Sativex in Multiple Sclerosis Spasticity http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=lmmbxsdo3izg7bp Fri, 22 Jun 2012 06:32:27 GMT LONDON, May 8 (Reuters) - GW Pharmaceuticals PLC: * Pharma - sativex mutual recognition procedure closes with http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=3hh96s2t3rfvt8a Tue, 08 May 2012 06:24:18 GMT LONDON, Dec 22 (Reuters) - GW Pharmaceuticals PLC: * Sativex approved in Sweden for the treatment of spasticity due to multiple http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=nsb7u1txuo8k7yn Thu, 22 Dec 2011 07:22:34 GMT LONDON, Nov 22 (Reuters) - GW Pharmaceuticals PLC: * Files new regulatory application to expand sativex  approvals to additional http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=j18siclyfde0zm8 Tue, 22 Nov 2011 07:24:46 GMT LONDON, Nov 17 (Reuters) - GW Pharmaceuticals PLC: * European patent granted for Sativex formulation http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=1nn8rnf58vydgb7 Thu, 17 Nov 2011 07:18:45 GMT LONDON, July 18 (Reuters) - GW Pharmaceuticals PLC: * Launch in Denmark of Sativex * Almirall holds the marketing rights to this medicine in Europe (except the United Kingdom) http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=j3a5hmn2k7eastn Mon, 18 Jul 2011 06:19:22 GMT LONDON, July 4 (Reuters) - GW Pharmaceuticals PLC: * Sativex launched in Germany ((London Equities Newsroom; +44 20 7542 7717)) http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=drqs9zlck55zfls Mon, 04 Jul 2011 06:26:19 GMT LONDON, June 30 (Reuters) - GW Pharmaceuticals PLC: * Second phase III Sativex cancer pain trial commences http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=c5yuq9w69ewxxu1 Thu, 30 Jun 2011 06:20:24 GMT LONDON, June 8 (Reuters) - GW Pharmaceuticals PLC: * Sativex approved in Denmark for the treatment of spasticity due to multiple http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=sle9g48g4nn2dtc Wed, 08 Jun 2011 06:19:54 GMT LONDON, May 26 (Reuters) - GW Pharmaceuticals PLC: * Sativex approved in Germany for the treatment of spasticity due to multiple http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=fi05mq5jn9rm50f Thu, 26 May 2011 06:21:25 GMT Europe Real-time Equity News UK Stocks on the move http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=1fd0br71yemoozn Tue, 17 May 2011 08:28:49 GMT LONDON, May 17 (Reuters) - GW Pharmaceuticals PLC: * Net profit before tax of £3.1M (H1 2010: £2.7M loss) http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=g4v2is4wscl7grc Tue, 17 May 2011 06:24:44 GMT LONDON, April 20 (Reuters) - GW Pharmaceuticals PLC: * US patent granted for Sativex in cancer pain http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=a556jlmz32hmoqd Wed, 20 Apr 2011 06:20:30 GMT LONDON, April 15 (Reuters) - GW Pharmaceuticals PLC: * Sativex oromucosal spray has been approved in the Czech Republic as a treatment for spasticity due to Multiple Sclerosis http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=8rwo2jegayh5ps9 Fri, 15 Apr 2011 06:19:26 GMT By Paul Sandle LONDON, April 11 (Reuters) - GW Pharmaceuticals has signed up Novartis to sell its cannabis-based drug Sativex in a range of markets, marking a key endorsement for the treatment from the major Swiss pharmaceutical company. http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=apmysti68itouc1 Mon, 11 Apr 2011 09:17:36 GMT April 11 (Reuters) - GW Pharmaceuticals PLC: * Peel Hunt raises GW Pharmaceuticals Plc price target by 11 percent to http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=1as6bk8iai3b1ml Mon, 11 Apr 2011 08:02:02 GMT LONDON, April 11 (Reuters) - GW Pharmaceuticals has signed up Novartis to sell its cannabis-based drug Sativex in a range of markets, marking a key endorsement for the treatment from the major Swiss pharmaceutical company. http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=ciicoo5vx2bn6n3 Mon, 11 Apr 2011 07:21:34 GMT LONDON, April 11 (Reuters) - GW Pharma: * Gw Pharma says Novartis to commercialise sativex in http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=eopjdwbqwodvhcf Mon, 11 Apr 2011 06:26:02 GMT LONDON, March 22 (Reuters) - GW Pharmaceuticals Plc's pioneering cannabis drug Sativex has been recommended for approval in the six other European countries targeted by the British company and Spanish partner Almirall. http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=emr7vi8pzfaqcwz Tue, 22 Mar 2011 08:26:20 GMT LONDON, March 22 (Reuters) - GW Pharmaceuticals PLC: * Sativex mutual recognition procedure closes with recommendation for approval http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=ee37qb7mfuhsrh5 Tue, 22 Mar 2011 07:20:18 GMT LONDON, March 14 (Reuters) - GW Pharmaceuticals PLC: * Sativex has been launched in Spain by gw's marketing partner almirall, s.a. http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=6fs0t6y4xxi3obk Mon, 14 Mar 2011 07:18:37 GMT LONDON, Feb 17 (Reuters) - GW Pharmaceuticals PLC: * Sativex granted reimbursement in Spain http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=3yn2251p8x9agsx Thu, 17 Feb 2011 07:42:56 GMT By Brenda Goh LONDON, Nov 23 (Reuters) - GW Pharmaceuticals' profits rose sharply following the successful launch of its cannabis-derived drug Sativex in Britain, and it said it had started final-stage trials of the medicine to treat cancer pain. http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=4pf4dxcn9zm2jyi Tue, 23 Nov 2010 10:34:08 GMT By Brenda Goh LONDON, Nov 23 (Reuters) - GW Pharmaceuticals' profits rose sharply following the successful launch of its cannabis-derived drug Sativex in Britain, and it said it had started final-stage trials of the medicine to treat cancer pain. http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=ytfgsyymj6tw1xt Tue, 23 Nov 2010 10:33:34 GMT LONDON, Nov 23 (Reuters) - GW Pharmaceuticals' profits rose sharply following the successful launch of its cannabis-derived drug Sativex in Britain and the company said it had started final-stage trials of the medicine in cancer pain. http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=pcs1dvpq36fv378 Tue, 23 Nov 2010 09:03:24 GMT LONDON, Nov 22 (Reuters) - GW Pharmaceuticals' profits rose sharply following the successful launch of its cannabis-derived drug Sativex in Britain and the company said it had started final-stage trials of the medicine in cancer pain. http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=xd6gvvbxwb8vnea Tue, 23 Nov 2010 08:59:49 GMT Nov 23 (Reuters) - GW Pharmaceuticals Plc: * Kbc peel hunt raises GW Pharmaceuticals Plc price target to 160P from http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=63kqes19crl5vju Tue, 23 Nov 2010 08:39:40 GMT LONDON, Nov 23 (Reuters) - GW Pharmaceuticals Plc: * Net profit before tax increased to £4.6M (2009: £1.2M) http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=arqnkam0etyyc5t Tue, 23 Nov 2010 07:22:29 GMT By Ben Hirschler LONDON, Nov 5 (Reuters) - Four months into its launch, GW Pharmaceuticals Plc's pioneering cannabis drug Sativex is getting a mixed reception from healthcare authorities across Britain, its first European market. http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=4j43ksrxuo99zmt Fri, 05 Nov 2010 13:06:18 GMT LONDON, Nov 3 (Reuters) - GW Pharmaceuticals Plc: * Sativex approved in New Zealand for the treatment of spasticity due to http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=pirmmvug5won4ou Wed, 03 Nov 2010 07:26:28 GMT LONDON, Sept 30 (Reuters) - GW Pharmaceuticals Plc: * Starts phase iia study programme evaluating new cannabinoid medicines in type http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=0xu1z4yutcnbwvf Thu, 30 Sep 2010 06:25:41 GMT LONDON, Sept 22 (Reuters) - GW Pharmaceuticals Plc: * Phase II clinical Study shows sativex has some beneficial effect for bladder symptoms in patients with ms http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=lom1annqyyid6aj Wed, 22 Sep 2010 06:30:18 GMT LONDON, Aug 31 (Reuters) - GW Pharmaceuticals Plc: * Health Canada grants full approval of Sativex for the treatment of http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=5701w47nbgrf20a Tue, 31 Aug 2010 06:22:41 GMT LONDON, July 28 (Reuters) - GW Pharmaceuticals Plc's cannabis-derived medicine Sativex has been approved in its second European market, Spain, as an add-on therapy for treating spasticity in patients with multiple sclerosis (MS). http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=easm26l6vnz5enx Wed, 28 Jul 2010 08:46:15 GMT LONDON, July 28 (Reuters) - GW Pharmaceuticals Plc's cannabis-derived medicine Sativex has been approved in its second European market, Spain, as an add-on therapy for treating spasticity in patients with multiple sclerosis (MS). http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=ln975mh8ycflxcm Wed, 28 Jul 2010 06:51:16 GMT MADRID, July 28 (Reuters) - Almirall SA: * Says Sativex multiple sclerosis medication gets regulatory approval in Spain http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=9rj8yssc1epqzf5 Wed, 28 Jul 2010 06:25:04 GMT LONDON, July 28 (Reuters) - GW Pharmaceuticals Plc: * Sativex receives regulatory authorisation in Spain http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=obw0v2i842flym5 Wed, 28 Jul 2010 06:23:18 GMT The Daily Telegraph APOLLO THREATENS TO WITHDRAW OFFER FOR BRIT OVER LACK OF ACCESS Apollo, the private equity firm, has threatened to http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=43jqr4hlkh46mse Sat, 03 Jul 2010 02:45:48 GMT The Daily Telegraph APOLLO THREATENS TO WITHDRAW OFFER FOR BRIT OVER LACK OF ACCESS Apollo, the private equity firm, has threatened to http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=441uapwuyq8legf Sat, 03 Jul 2010 02:45:38 GMT The Daily Telegraph APOLLO THREATENS TO WITHDRAW OFFER FOR BRIT OVER LACK OF ACCESS Apollo, the private equity firm, has threatened to http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=nqn5atqsg47htsg Sat, 03 Jul 2010 02:45:01 GMT The Daily Telegraph APOLLO THREATENS TO WITHDRAW OFFER FOR BRIT OVER LACK OF ACCESS Apollo, the private equity firm, has threatened to http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=h35bhlhumy6q1sz Sat, 03 Jul 2010 02:44:12 GMT LONDON, July 2 (Reuters) - GW Pharmaceuticals Plc: * Since the launch of sativex, GW confirms nhs prescriptions are being written http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=8i3ibxe65ma4lcv Fri, 02 Jul 2010 09:26:22 GMT LONDON, June 30 (Reuters) - GW Pharmaceuticals Plc: * Signed 3 year extension to global cannabinoid research collaboration with http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=s7mlleka35bhhqu Wed, 30 Jun 2010 06:49:22 GMT By Ben Hirschler and Paul Sandle LONDON, June 21 (Reuters) - GW Pharmaceuticals Plc's cannabis-derived medicine Sativex will cost approximately 11 pounds ($16.3) a day when used as a prescription treatment in Britain for spasticity in patients with multiple sclerosis. http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=xrgs3e1xfclzmh6 Mon, 21 Jun 2010 10:23:41 GMT LONDON, June 21 (Reuters) - GW Pharmaceuticals Plc's cannabis-derived medicine Sativex will cost approximately 11 pounds ($16.31) a day when used as a prescription treatment in Britain for spasticity in patients with multiple sclerosis. http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=8zcc60bo0vqw4ui Mon, 21 Jun 2010 06:54:41 GMT Monday June 21 2010 The Daily Telegraph LOCAL AUTHORITIY 'SICKIES' TWICE THOSE OF PRIVATE SECTOR http://www.lse.co.uk/ShareNews.asp?shareprice=GWP&ArticleCode=6vn4lyeuhpdg2zp Mon, 21 Jun 2010 00:59:36 GMT